- All sections
- C - Chemistry; metallurgy
- C07D - Heterocyclic compounds
- C07D 235/04 - Benzimidazoles; Hydrogenated benzimidazoles
Patent holdings for IPC class C07D 235/04
Total number of patents in this class: 315
10-year publication summary
|
19
|
17
|
11
|
21
|
14
|
22
|
26
|
17
|
12
|
2
|
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Boehringer Ingelheim International GmbH | 4629 |
10 |
| UCB Biopharma SRL | 626 |
10 |
| Merck Sharp & Dohme Corp. | 2247 |
5 |
| Daewoong Pharmaceutical Co., Ltd. | 283 |
5 |
| Universal Display Corporation | 1678 |
5 |
| Cephalon LLC | 88 |
5 |
| Nitto Denko Corporation | 7879 |
4 |
| Taisho Pharmaceutical Co., Ltd. | 844 |
4 |
| Toyama Chemical Co., Ltd. | 114 |
4 |
| Vectus Biosystems Limited | 36 |
4 |
| Bristol-myers Squibb Company | 5080 |
3 |
| Centre National de La Recherche Scientifique | 9632 |
3 |
| Semiconductor Energy Laboratory Co., Ltd. | 10902 |
3 |
| University of Florida Research Foundation, Inc. | 3883 |
3 |
| HT Materials Corporation | 14 |
3 |
| MEI Pharma, Inc. | 80 |
3 |
| vTv Therapeutics LLC | 159 |
3 |
| Goldfinch bio, Inc. | 32 |
3 |
| PI Industries Ltd | 147 |
3 |
| Terns Pharmaceuticals, Inc. | 42 |
3 |
| Other owners | 229 |